Concepedia

Thomas Kerbusch

TK

33

Publications

1.6K

Citations

21

H-Index

1997

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Slotervaartziekenhuis

Merck & Co., Inc., Rahway, NJ, USA (United States)

Uppsala University

Utrecht University

Thomas Kerbusch is an author at The Netherlands Cancer Institute specializing in medicine, pharmacology, and pharmacokinetics.

ORCID

Top concepts

Publications per year

1997–2019

33

Publications

33

Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies

Radojka M. Savić, Daniël M. Jonker, Thomas Kerbusch et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2007 · 487 citations

, , +8

Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)

Zereunesay Desta, Thomas Kerbusch, D. A. Flockhart · Clinical Pharmacology & Therapeutics · 1999 · 129 citations

Identification and Characterization of Human Cytochrome P450 Isoforms Interacting with Pimozide

Zeruesenay Desta, Thomas Kerbusch, Nadia Soukhova et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 75 citations

Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effect of Synthetic Opioids in the Rat: Correlation with the Interaction at the Mu-Opioid Receptor

Eugène Cox, Thomas Kerbusch, Piet H. van der Graaf et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 74 citations

Studies on the Mechanism of a Fatal Clarithromycin-Pimozide Interaction in a Patient With Tourette Syndrome

David A. Flockhart, Milou-Daniel Drici, Thomas Kerbusch et al. · Journal of Clinical Psychopharmacology · 2000 · 72 citations

Rows per page

1–5 of 33